Daniel Ojeda
WRITTEN BY Daniel Ojeda
With A New Medical Device and Accompanying Platform, Roche Advances its Digital Ecosystem
2022-01-14
With New Funding, ACELYRIN Licenses First Therapeutic and Leaps into Late-Stage Trials for Autoimmune Diseases
2021-11-17